PerkinElmer Adds Infectious Disease Testing By Acquiring Oxford Immunotec For $591M

PerkinElmer’s sales and testing capacity will expand the reach of Oxford Immunotec’s proprietary interferon gamma release tuberculosis assay technology.

Tuberculosis - vector illustration on gray background
mycobacterium tuberculosis • Source: shutterstock.com

PerkinElmer has agreed to buy Oxford Immunotec for $591m to add the UK company’s T cell immunology expertise and proprietary tuberculosis testing technology to its line of infectious disease testing products.

“Oxford Immunotec’s highly sensitive test and their team’s passion for solving complex health issues make it a natural fit with...

More from Deals

More from Business